Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.83 B JPY
0.00 JPY
10.87 M
About CHORDIA THERAPEUTICS INC
Sector
CEO
Hiroshi Miyake
Headquarters
Fujisawa
Website
Founded
2017
ISIN
JP3283730004
FIGI
BBG01HTQQWW8
Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 190A is 316 JPY — it has decreased by −0.32% in the past 24 hours. Watch CHORDIA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CHORDIA THERAPEUTICS INC stocks are traded under the ticker 190A.
190A stock has risen by 1.28% compared to the previous week, the month change is a 21.07% rise, over the last year CHORDIA THERAPEUTICS INC has showed a 23.92% increase.
190A reached its all-time high on Aug 14, 2024 with the price of 930 JPY, and its all-time low was 142 JPY and was reached on Jun 21, 2024. View more price dynamics on 190A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
190A stock is 6.07% volatile and has beta coefficient of 0.32. Track CHORDIA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is CHORDIA THERAPEUTICS INC there?
Yes, you can track CHORDIA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
CHORDIA THERAPEUTICS INC is going to release the next earnings report on Jan 14, 2025. Keep track of upcoming events with our Earnings Calendar.
190A net income for the last quarter is −649.65 M JPY, while the quarter before that showed −374.87 M JPY of net income which accounts for −73.30% change. Track more CHORDIA THERAPEUTICS INC financial stats to get the full picture.
No, 190A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 22.00 employees. See our rating of the largest employees — is CHORDIA THERAPEUTICS INC on this list?
Like other stocks, 190A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHORDIA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.